GlassScriptPhysician profile
Kylie Allissa Mcclain
NPI 1881281723
$665.01
in general payments reported to CMS, 2019-2025
9 companies · $328 in 2025
The $328 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18.30 · 2022: $54.56 · 2023: $90.31 · 2024: $174 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $239.12 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $133.17 | 2024-2025 | Veozah |
| Pfizer INC. | $104.18 | 2022-2025 | |
| Sage Therapeutics, LLC | $77.29 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $30.65 | 2024 | |
| Supernus Pharmaceuticals, INC. | $24.27 | 2025 | Qelbree |
| Smith+Nephew, INC. | $21.17 | 2024 | Pico |
| Genentech USA, INC. | $18.30 | 2021 | |
| Sumitomo Pharma America, INC. | $16.86 | 2025 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kylie Mcclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.